1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Medical & Pharmaceutical Grade Activated Carbon Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Medical & Pharmaceutical Grade Activated Carbon by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Medical & Pharmaceutical Grade Activated Carbon by Country/Region, 2018, 2022 & 2029
2.2 Medical & Pharmaceutical Grade Activated Carbon Segment by Type
2.2.1 Powder Activated Carbon
2.2.2 Granular Activated Carbon
2.2.3 Others
2.3 Medical & Pharmaceutical Grade Activated Carbon Sales by Type
2.3.1 Global Medical & Pharmaceutical Grade Activated Carbon Sales Market Share by Type (2018-2023)
2.3.2 Global Medical & Pharmaceutical Grade Activated Carbon Revenue and Market Share by Type (2018-2023)
2.3.3 Global Medical & Pharmaceutical Grade Activated Carbon Sale Price by Type (2018-2023)
2.4 Medical & Pharmaceutical Grade Activated Carbon Segment by Application
2.4.1 Medical
2.4.2 Pharmaceutical
2.5 Medical & Pharmaceutical Grade Activated Carbon Sales by Application
2.5.1 Global Medical & Pharmaceutical Grade Activated Carbon Sale Market Share by Application (2018-2023)
2.5.2 Global Medical & Pharmaceutical Grade Activated Carbon Revenue and Market Share by Application (2018-2023)
2.5.3 Global Medical & Pharmaceutical Grade Activated Carbon Sale Price by Application (2018-2023)
3 Global Medical & Pharmaceutical Grade Activated Carbon by Company
3.1 Global Medical & Pharmaceutical Grade Activated Carbon Breakdown Data by Company
3.1.1 Global Medical & Pharmaceutical Grade Activated Carbon Annual Sales by Company (2018-2023)
3.1.2 Global Medical & Pharmaceutical Grade Activated Carbon Sales Market Share by Company (2018-2023)
3.2 Global Medical & Pharmaceutical Grade Activated Carbon Annual Revenue by Company (2018-2023)
3.2.1 Global Medical & Pharmaceutical Grade Activated Carbon Revenue by Company (2018-2023)
3.2.2 Global Medical & Pharmaceutical Grade Activated Carbon Revenue Market Share by Company (2018-2023)
3.3 Global Medical & Pharmaceutical Grade Activated Carbon Sale Price by Company
3.4 Key Manufacturers Medical & Pharmaceutical Grade Activated Carbon Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Medical & Pharmaceutical Grade Activated Carbon Product Location Distribution
3.4.2 Players Medical & Pharmaceutical Grade Activated Carbon Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Medical & Pharmaceutical Grade Activated Carbon by Geographic Region
4.1 World Historic Medical & Pharmaceutical Grade Activated Carbon Market Size by Geographic Region (2018-2023)
4.1.1 Global Medical & Pharmaceutical Grade Activated Carbon Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Medical & Pharmaceutical Grade Activated Carbon Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Medical & Pharmaceutical Grade Activated Carbon Market Size by Country/Region (2018-2023)
4.2.1 Global Medical & Pharmaceutical Grade Activated Carbon Annual Sales by Country/Region (2018-2023)
4.2.2 Global Medical & Pharmaceutical Grade Activated Carbon Annual Revenue by Country/Region (2018-2023)
4.3 Americas Medical & Pharmaceutical Grade Activated Carbon Sales Growth
4.4 APAC Medical & Pharmaceutical Grade Activated Carbon Sales Growth
4.5 Europe Medical & Pharmaceutical Grade Activated Carbon Sales Growth
4.6 Middle East & Africa Medical & Pharmaceutical Grade Activated Carbon Sales Growth
5 Americas
5.1 Americas Medical & Pharmaceutical Grade Activated Carbon Sales by Country
5.1.1 Americas Medical & Pharmaceutical Grade Activated Carbon Sales by Country (2018-2023)
5.1.2 Americas Medical & Pharmaceutical Grade Activated Carbon Revenue by Country (2018-2023)
5.2 Americas Medical & Pharmaceutical Grade Activated Carbon Sales by Type
5.3 Americas Medical & Pharmaceutical Grade Activated Carbon Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Medical & Pharmaceutical Grade Activated Carbon Sales by Region
6.1.1 APAC Medical & Pharmaceutical Grade Activated Carbon Sales by Region (2018-2023)
6.1.2 APAC Medical & Pharmaceutical Grade Activated Carbon Revenue by Region (2018-2023)
6.2 APAC Medical & Pharmaceutical Grade Activated Carbon Sales by Type
6.3 APAC Medical & Pharmaceutical Grade Activated Carbon Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Medical & Pharmaceutical Grade Activated Carbon by Country
7.1.1 Europe Medical & Pharmaceutical Grade Activated Carbon Sales by Country (2018-2023)
7.1.2 Europe Medical & Pharmaceutical Grade Activated Carbon Revenue by Country (2018-2023)
7.2 Europe Medical & Pharmaceutical Grade Activated Carbon Sales by Type
7.3 Europe Medical & Pharmaceutical Grade Activated Carbon Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Medical & Pharmaceutical Grade Activated Carbon by Country
8.1.1 Middle East & Africa Medical & Pharmaceutical Grade Activated Carbon Sales by Country (2018-2023)
8.1.2 Middle East & Africa Medical & Pharmaceutical Grade Activated Carbon Revenue by Country (2018-2023)
8.2 Middle East & Africa Medical & Pharmaceutical Grade Activated Carbon Sales by Type
8.3 Middle East & Africa Medical & Pharmaceutical Grade Activated Carbon Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Medical & Pharmaceutical Grade Activated Carbon
10.3 Manufacturing Process Analysis of Medical & Pharmaceutical Grade Activated Carbon
10.4 Industry Chain Structure of Medical & Pharmaceutical Grade Activated Carbon
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Medical & Pharmaceutical Grade Activated Carbon Distributors
11.3 Medical & Pharmaceutical Grade Activated Carbon Customer
12 World Forecast Review for Medical & Pharmaceutical Grade Activated Carbon by Geographic Region
12.1 Global Medical & Pharmaceutical Grade Activated Carbon Market Size Forecast by Region
12.1.1 Global Medical & Pharmaceutical Grade Activated Carbon Forecast by Region (2024-2029)
12.1.2 Global Medical & Pharmaceutical Grade Activated Carbon Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Medical & Pharmaceutical Grade Activated Carbon Forecast by Type
12.7 Global Medical & Pharmaceutical Grade Activated Carbon Forecast by Application
13 Key Players Analysis
13.1 Kuraray
13.1.1 Kuraray Company Information
13.1.2 Kuraray Medical & Pharmaceutical Grade Activated Carbon Product Portfolios and Specifications
13.1.3 Kuraray Medical & Pharmaceutical Grade Activated Carbon Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Kuraray Main Business Overview
13.1.5 Kuraray Latest Developments
13.2 Osaka Gas Chemicals
13.2.1 Osaka Gas Chemicals Company Information
13.2.2 Osaka Gas Chemicals Medical & Pharmaceutical Grade Activated Carbon Product Portfolios and Specifications
13.2.3 Osaka Gas Chemicals Medical & Pharmaceutical Grade Activated Carbon Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Osaka Gas Chemicals Main Business Overview
13.2.5 Osaka Gas Chemicals Latest Developments
13.3 YL
13.3.1 YL Company Information
13.3.2 YL Medical & Pharmaceutical Grade Activated Carbon Product Portfolios and Specifications
13.3.3 YL Medical & Pharmaceutical Grade Activated Carbon Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 YL Main Business Overview
13.3.5 YL Latest Developments
13.4 CABOT
13.4.1 CABOT Company Information
13.4.2 CABOT Medical & Pharmaceutical Grade Activated Carbon Product Portfolios and Specifications
13.4.3 CABOT Medical & Pharmaceutical Grade Activated Carbon Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 CABOT Main Business Overview
13.4.5 CABOT Latest Developments
13.5 Ingevity
13.5.1 Ingevity Company Information
13.5.2 Ingevity Medical & Pharmaceutical Grade Activated Carbon Product Portfolios and Specifications
13.5.3 Ingevity Medical & Pharmaceutical Grade Activated Carbon Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Ingevity Main Business Overview
13.5.5 Ingevity Latest Developments
13.6 Haycarb
13.6.1 Haycarb Company Information
13.6.2 Haycarb Medical & Pharmaceutical Grade Activated Carbon Product Portfolios and Specifications
13.6.3 Haycarb Medical & Pharmaceutical Grade Activated Carbon Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Haycarb Main Business Overview
13.6.5 Haycarb Latest Developments
13.7 JD
13.7.1 JD Company Information
13.7.2 JD Medical & Pharmaceutical Grade Activated Carbon Product Portfolios and Specifications
13.7.3 JD Medical & Pharmaceutical Grade Activated Carbon Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 JD Main Business Overview
13.7.5 JD Latest Developments
13.8 Shenhua Group
13.8.1 Shenhua Group Company Information
13.8.2 Shenhua Group Medical & Pharmaceutical Grade Activated Carbon Product Portfolios and Specifications
13.8.3 Shenhua Group Medical & Pharmaceutical Grade Activated Carbon Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Shenhua Group Main Business Overview
13.8.5 Shenhua Group Latest Developments
13.9 ADA-ES
13.9.1 ADA-ES Company Information
13.9.2 ADA-ES Medical & Pharmaceutical Grade Activated Carbon Product Portfolios and Specifications
13.9.3 ADA-ES Medical & Pharmaceutical Grade Activated Carbon Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 ADA-ES Main Business Overview
13.9.5 ADA-ES Latest Developments
13.10 Fujian Xinsen Carbon
13.10.1 Fujian Xinsen Carbon Company Information
13.10.2 Fujian Xinsen Carbon Medical & Pharmaceutical Grade Activated Carbon Product Portfolios and Specifications
13.10.3 Fujian Xinsen Carbon Medical & Pharmaceutical Grade Activated Carbon Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Fujian Xinsen Carbon Main Business Overview
13.10.5 Fujian Xinsen Carbon Latest Developments
13.11 MULINSEN ACTIVATED CARBON
13.11.1 MULINSEN ACTIVATED CARBON Company Information
13.11.2 MULINSEN ACTIVATED CARBON Medical & Pharmaceutical Grade Activated Carbon Product Portfolios and Specifications
13.11.3 MULINSEN ACTIVATED CARBON Medical & Pharmaceutical Grade Activated Carbon Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 MULINSEN ACTIVATED CARBON Main Business Overview
13.11.5 MULINSEN ACTIVATED CARBON Latest Developments
13.12 Shanxi XinHua Chemical
13.12.1 Shanxi XinHua Chemical Company Information
13.12.2 Shanxi XinHua Chemical Medical & Pharmaceutical Grade Activated Carbon Product Portfolios and Specifications
13.12.3 Shanxi XinHua Chemical Medical & Pharmaceutical Grade Activated Carbon Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Shanxi XinHua Chemical Main Business Overview
13.12.5 Shanxi XinHua Chemical Latest Developments
13.13 Boyce Carbon
13.13.1 Boyce Carbon Company Information
13.13.2 Boyce Carbon Medical & Pharmaceutical Grade Activated Carbon Product Portfolios and Specifications
13.13.3 Boyce Carbon Medical & Pharmaceutical Grade Activated Carbon Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Boyce Carbon Main Business Overview
13.13.5 Boyce Carbon Latest Developments
13.14 DESOTEC Activated Carbon
13.14.1 DESOTEC Activated Carbon Company Information
13.14.2 DESOTEC Activated Carbon Medical & Pharmaceutical Grade Activated Carbon Product Portfolios and Specifications
13.14.3 DESOTEC Activated Carbon Medical & Pharmaceutical Grade Activated Carbon Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 DESOTEC Activated Carbon Main Business Overview
13.14.5 DESOTEC Activated Carbon Latest Developments
13.15 HuaHui-Carbon
13.15.1 HuaHui-Carbon Company Information
13.15.2 HuaHui-Carbon Medical & Pharmaceutical Grade Activated Carbon Product Portfolios and Specifications
13.15.3 HuaHui-Carbon Medical & Pharmaceutical Grade Activated Carbon Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 HuaHui-Carbon Main Business Overview
13.15.5 HuaHui-Carbon Latest Developments
13.16 ZHI XING
13.16.1 ZHI XING Company Information
13.16.2 ZHI XING Medical & Pharmaceutical Grade Activated Carbon Product Portfolios and Specifications
13.16.3 ZHI XING Medical & Pharmaceutical Grade Activated Carbon Sales, Revenue, Price and Gross Margin (2018-2023)
13.16.4 ZHI XING Main Business Overview
13.16.5 ZHI XING Latest Developments
13.17 Silcarbon Aktivkohle GmbH
13.17.1 Silcarbon Aktivkohle GmbH Company Information
13.17.2 Silcarbon Aktivkohle GmbH Medical & Pharmaceutical Grade Activated Carbon Product Portfolios and Specifications
13.17.3 Silcarbon Aktivkohle GmbH Medical & Pharmaceutical Grade Activated Carbon Sales, Revenue, Price and Gross Margin (2018-2023)
13.17.4 Silcarbon Aktivkohle GmbH Main Business Overview
13.17.5 Silcarbon Aktivkohle GmbH Latest Developments
13.18 Jiangsu Zhuxi Activated Carbon
13.18.1 Jiangsu Zhuxi Activated Carbon Company Information
13.18.2 Jiangsu Zhuxi Activated Carbon Medical & Pharmaceutical Grade Activated Carbon Product Portfolios and Specifications
13.18.3 Jiangsu Zhuxi Activated Carbon Medical & Pharmaceutical Grade Activated Carbon Sales, Revenue, Price and Gross Margin (2018-2023)
13.18.4 Jiangsu Zhuxi Activated Carbon Main Business Overview
13.18.5 Jiangsu Zhuxi Activated Carbon Latest Developments
13.19 Inner Mongolia TaiXi Coal Group
13.19.1 Inner Mongolia TaiXi Coal Group Company Information
13.19.2 Inner Mongolia TaiXi Coal Group Medical & Pharmaceutical Grade Activated Carbon Product Portfolios and Specifications
13.19.3 Inner Mongolia TaiXi Coal Group Medical & Pharmaceutical Grade Activated Carbon Sales, Revenue, Price and Gross Margin (2018-2023)
13.19.4 Inner Mongolia TaiXi Coal Group Main Business Overview
13.19.5 Inner Mongolia TaiXi Coal Group Latest Developments
13.20 Active Char Products
13.20.1 Active Char Products Company Information
13.20.2 Active Char Products Medical & Pharmaceutical Grade Activated Carbon Product Portfolios and Specifications
13.20.3 Active Char Products Medical & Pharmaceutical Grade Activated Carbon Sales, Revenue, Price and Gross Margin (2018-2023)
13.20.4 Active Char Products Main Business Overview
13.20.5 Active Char Products Latest Developments
14 Research Findings and Conclusion
| ※参考情報 医療および製薬用の活性炭は、医療分野において非常に重要な素材とされています。活性炭とは、炭素を基本とする多孔質な物質で、その特性によってさまざまな用途が広がっています。特に医療や製薬においては、毒物の吸着、薬剤の分離、さらには浄水処理など、重要な役割を果たしています。 活性炭の定義としては、非常に多くの微細な孔を持つ炭素材料であり、表面積が極めて大きいことが特徴です。この多孔性により、活性炭は特定の物質を選択的に吸着する能力を持ちます。医療用と製薬用の活性炭は、通常の活性炭と比較して、より厳しい品質管理が行われます。これにより、製品の安全性や効果が保証されています。 医療用活性炭は、主に毒物や薬物の中毒に対する解毒剤として使用されます。例えば、急性中毒の患者に対して、活性炭を経口投与することにより、未消化の毒物を腸内で吸着し、その体内への吸収を防ぐ効果があります。このプロセスは、迅速かつ効果的に毒物の影響を軽減するため、重要な治療手段とされています。 さらに、製薬用の活性炭は、医薬品の製造過程においてさまざまな用途があります。例えば、医薬品の純度を向上させるために、不純物の除去に使用されます。また、活性炭は、薬剤の放出特性を調整するためのマトリックスとしても利用されることがあります。これにより、薬剤の効果的な投与が可能となります。 活性炭の種類には、主に木炭、石炭、ココナッツ殻由来の活性炭などがあります。異なる原料から作られる活性炭は、それぞれ異なる吸着特性を持ち、特定の用途に応じて使用されます。木炭由来の活性炭は、特に甲殻類や植物由来の薬剤の吸着に効果的とされます。一方、ココナッツ殻から作られる活性炭は、非常に高い比表面積を持ち、医療や製薬の分野で広く使用されています。 関連技術としては、活性炭の改質技術に注目が集まっています。活性炭の表面に特定の機能基を導入することで、特定の物質に対する吸着能力をさらに向上させることができます。このような改質は、特定の医薬品の吸着や分離の精度を向上させるために重要な技術です。また、ナノテクノロジーの活用も進んでおり、ナノサイズの活性炭粒子を用いることで、より効果的な吸着性能を得る手法が研究されています。 最後に、医療および製薬用の活性炭の市場は、近年の健康志向の高まりや、環境問題への関心から拡大を続けています。特に、天然由来の活性炭の需要が増加しており、持続可能な素材としての評価が高まっています。このような動向により、活性炭は今後も医療や製薬分野において重要な役割を果たし続けることでしょう。 |
